Danone CEO Discusses Impact of Weight Loss Drugs in Food Industry
Thursday, 4 April 2024, 10:45
Danone CEO Addresses Impact of Weight Loss Drugs
The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new regime.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.